" What lies behind us, what lies before us, are small matters compared to what lies within us" R.W. Emmerson
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$DRIO. chart looking good.. imo
$SURG getting some traction on PPS .57 x .575 ...looking for a breakout into 60s range shortly... looks like sellers are dried up..imo
DarioHealth Granted License by Health Canada to Sell Dario Smart Glucose Meters for Lightning® Connector Enabled iPhones
Significant expansion of Dario's Canadian market opportunity to include iPhone 7, 8, and iPhone X user
NEW YORK and CAESAREA, Israel, March 20, 2019 /PRNewswire/ -- Global digital therapeutics innovator, DarioHealth Corp. (DRIO), announced today the receipt of a license from Health Canada to sell its Dario™ Blood Glucose Monitoring System for Lightning power connector-enabled iPhone smart mobile devices.
iPhone users in Canada, including those with prior models that use a headphone jack, as well as those with the Lightning power connector, will now have access to DarioHealth's acclaimed digital diabetes products and lifestyle management app features, like glucose level tracking, real time patient glucose data access for healthcare providers, carb counting, hypo alerts, amongst other diabetes countering features.
https://finance.yahoo.com/news/dariohealth-granted-license-health-canada-123000517.html
$DRIO, $CTXR
$CTXR Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets. For complete overview click link:
https://bit.ly/2SOBhlA
Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets. For complete overview click link:
https://bit.ly/2SOBhlA
This one looks ripe to go.. Up on the bid.. looking forward to this one moving..
***Citius Pharmaceuticals Inc. (CTXR) Licenses Mino-Wrap From MD Anderson Cancer Center
- New technology designed to reduce infections after implantation of devices
- First target is breast tissue expanders
- Intended for minimizing serious complications of post-operative infections associated with implants
- Expands relationship with the world's top rated cancer center
CRANFORD, N.J., Jan. 8, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") ("Company") (CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today reported that a definitive license agreement has been reached with MD Anderson Cancer Center ("MDACC") to develop and commercialize a novel approach to reducing post-operative infections associated with surgical implants. The initial product called "Mino-Wrap", or CITI 101, is a liquefying gel-based wrap containing minocycline and rifampin for reducing tissue expander (TE) infections following breast reconstructive surgeries.
https://finance.yahoo.com/news/citius-licenses-mino-wrap-md-140000769.html
Citius Pharmaceuticals Inc. (CTXR) Licenses Mino-Wrap From MD Anderson Cancer Center
- New technology designed to reduce infections after implantation of devices
- First target is breast tissue expanders
- Intended for minimizing serious complications of post-operative infections associated with implants
- Expands relationship with the world's top rated cancer center
CRANFORD, N.J., Jan. 8, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") ("Company") (CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today reported that a definitive license agreement has been reached with MD Anderson Cancer Center ("MDACC") to develop and commercialize a novel approach to reducing post-operative infections associated with surgical implants. The initial product called "Mino-Wrap", or CITI 101, is a liquefying gel-based wrap containing minocycline and rifampin for reducing tissue expander (TE) infections following breast reconstructive surgeries.
https://finance.yahoo.com/news/citius-licenses-mino-wrap-md-140000769.html
THE PROGRESS
On March 5, 2019, Surge Holdings Inc. filed an application for uplisting to the NASDAQ Capital Market. The Company’s common stock will continue to trade on the OTCQB under its current symbol, SURG, during the NASDAQ review process and while the Company prepares to meet all the requirements for uplisting to NASDAQ.
https://surgeholdings.com/ceo-vision/
DarioHealth to Host Fourth Quarter and Year End 2018 Conference Call March 25, 2019
PR Newswire PR Newswire•March 18, 2019
Earnings Discussion and Business Update Scheduled for 9:00 am EDT
NEW YORK and CAESAREA, Israel, March 18, 2019 /PRNewswire/ -- Global digital therapeutics innovation leader DarioHealth Corp. (DRIO) today announced it will release its fourth quarter and year-end 2018 results on Monday, March 25, and host a conference call the same morning at 9:00 am EDT
https://finance.yahoo.com/news/dariohealth-host-fourth-quarter-end-130000027.html
Surge Holdings: The Unknown Story Of High Potential Growth
Summary
Surge Holdings is a virtually unknown company.
They have silently laid the groundwork for a new distribution channel across the US.
Their fin-tech offerings are life-enhancing products for people with economic challenges.
One interesting product is a free cellular plan that is paid for by ads.
Surge Holdings (SURG) is an almost unknown company with an interesting story to tell. They are rolling out their plan in 2019. If their plan is well received by consumers and corner markets – the upside potential over the next few years is very high. I estimate that the share price could be as high as $11 by 2021. I feel that the market does not yet understand this opportunity which is why the upside potential is so large.
Granted, this is a highly speculative stock where we are investing exclusively on future potential. But during 2019, we should see strong indications as to how successful Surge Holdings will be in executing their plan.
If you follow me on Seeking Alpha, you know me to be a dispassionate and analytical model designer. I create multi-factor ‘smart-beta’ models for family offices in addition to working as a part-time research consultant for a global quantitative asset management firm. What is it about the Surge Holdings story that has me thinking the upside potential is so big?
https://seekingalpha.com/article/4238650-surge-holdings-unknown-story-high-potential-growth?mod=mw_quote_news
$DRIO app is #4 on Amazons Best selling Blood Monitor. Headed to #1
In a statement, Erez Raphael, Chairman and CEO of DarioHealth, said: “We’ve been working tirelessly to bring forth a solution that would meet the rigorous standards required to achieve the FDA clearance. We are proud that our organization worked with agility to ensure connectivity to the latest Apple devices. This is a big breakthrough to receive the FDA’s marketing clearance for the Dario product on iPhone 7, 8 and X, and allows many of our past users who upgraded to these new iPhones to renew their Dario experience. This continues DarioHealth’s U.S. market progress, and truly opens the door for wide-scale expansion in this pivotal market. Of course, this milestone is a testament to our superb teamwork, and I am proud of the hard work and success that our talented team has achieved.”
yes.. I agree.. the stock looks like it is picking up traction.. I got this analyst report... it is dated ... but is looking spot on. Click on link below image...
https://bit.ly/2UFYQLq
Hearing whispers of press. . did everyone catch the CEOs last tweet... I am seeing $SURG symbol in platform trading rooms in a lot of NEW feeds..IMO...$SURG IS tightened up to blast forward.. if your not in the stock and watching.. you will not make any money .. if you are I would be adding to my position at these stupid low PPS... Has everyone forgeting the Goldman's report Target's...3.00 range... All jmho. GLTA??
What a solid day for $DRIO. it us clear that strength is coming into the market . ..who knows what's next . .. I'm. PPS ++++ I AM STARTING TO SEE $DRIO EVERYWHERE .. GLTA .
$DRIO DRIO Analyst Report Click on Link Below.
https://t.co/cmoL9CVxe3
$DSCR.. looking for a good dat tomorrow,,,eom
$DRIO.. looking for nice move north shortly Trading @ .68x .69 THIN to .90 range..eom
$DRIO Trading @ .68 x .69 Dario Blood Glucose Monitoring System
Finally, Diabetes Management Simplified
When was the last time you got excited about your blood glucose meter?
Well if you have the all-in-one Dario™ Blood Glucose Monitoring System in your pocket, then we know what the answer is! This new product has everything you need to properly monitor your blood glucose levels. Plus, it has 5 essential tools that aims to simplify diabetes management. I’m going to reveal them soon, but first let’s dig in and understand the issue at hand.
You see, until recently, diabetes kits were big and bulky. And even though keeping your diabetes at bay is a whole lot more than just checking your blood glucose levels, sadly that’s pretty much the only thing they were good for. In the digital age, though, we must demand more. With an abundant of technological advances in recent years, we have to rethink what is essential for a blood glucose monitor. Because you know that simplifying diabetes management is more than just measuring your blood glucose levels.
$DSCR... imo.. still calling a target of .0006 - .0007 range this week...looks like the REAL NEWS cycle has started.
yes a BIG forward movment with the company.. looking real to me...eom
$DSCR PRESS OUT... Discovery Minerals Ltd. Announces Completion of Joint Venture for Mining War Eagle Mountain Project
The Company Has Completed a Definitive Joint Venture Agreement with the Owners of the War Eagle Mountain Project to Fully Explore, Mine, and Process Ore Bodies. The Joint Venture Includes the Existing Mill Facility
PHOENIX, AZ, March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Discovery Minerals Ltd. (DSCR) an acquisition and development Company that targets natural resource properties primarily in precious metals and mining operations. Discovery Minerals is pleased to announce that they have completed a Joint Venture with the Owners of the War Eagle Mountain Project. Under the terms of the Joint Venture Discovery Minerals will be the operator of the mine and receive 50% of all net proceeds. The Owners have contributed their mining claims as well as the existing Mill Facility located on Silver City Road.
Russell Smith, CEO of Discovery Minerals, stated; “It has been a pleasure working with the owners of the War Eagle Mountain Project. War Eagle Mountain is a proven resource for Gold and Silver deposits and we are truly benefiting from the extensive historical operation reports and geology already completed as well as the owners’ knowledge of this rich project. The inclusion of the Mill Facility in the Joint Venture was extremely important as it will allow us to focus resources on commencing mining operations. Now that the Joint Venture agreement has been fully documented we will look to accelerate completion of the first phase mining plan. As previously announced our initial mining target is an extension of the Ore Fino Vein with approximately 70,000 tons of near surface ore. Girvan Jackson, Project Manager, and myself have already scheduled an immediate site visit with the geologists and mill engineer with a view to expedite the mining and precious metal production plan. We look forward to reporting compilation of the mining plan on schedule in April 2019 as well as other considerations to expand early operations and continue to create long term shareholder value.”
About Discovery Minerals Ltd.:
Discovery Minerals Ltd. (OTC PINK: DSCR) is an acquisition and development company that targets natural resource properties and cutting edge technology opportunities through its subsidiaries. The Board of Directors has determined that these activities be continued with an emphasis on early positive cash flow from any projects undertaken.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
Contact:
Discovery Minerals Ltd.
Info@discoveryminerals.com
Imho.....I am targeting .0006-7 range this week at least!!!! ... Game on people.. ??
imho.. Fridays trading was very postive..looking for a good week ahead....eom
$DSCR.. expecting a BIG weekahead.. eom
L2 was looking VERY strong friday in the afternoon session on $DRIO...eom
we are taking a very close look at this compny.. LOTS of potential!!!!...eom